Molecular Docking Studies of Flavone Derivatives as Inhibitors of RdRP Nora Virus: Computational Insights and Binding Affinity Analysis

ABSTRACT Human viruses with high mutation rates, such as the Nora Virus, pose significant challenges in biomedical research and antiviral drug development, necessitating the exploration of novel therapeutic strategies. The Nora Virus, classified under the genus Phlebovirus within the family Bunyaviridae, relies on RNA-dependent RNA polymerase (RdRP) for viral RNA replication, making RdRP a crucial target for antiviral intervention. In this study, we employed computational approaches, including molecular docking and molecular dynamics simulations, to investigate the inhibitory potential of selected flavone derivatives retrieved from the PubChem database against Nora Virus RdRP (PDB ID: 4LQ3). Ligands were prepared by optimizing their conformations and converting them into appropriate formats for docking with AutoDock Vina, while the protein structure was processed by removing extraneous molecules and defining the active site around key residues such as Cys196 and Cys305. The docking simulations revealed that Apigenin 7-O-Rutinoside exhibited the highest binding affinity with a binding energy of -9.8 kcal/mol, forming multiple hydrogen bonds and extensive hydrophobic interactions with critical amino acids including Glu510, Gly508, and Tyr341. Several other flavonoids, such as 8-Prenylnaringenin and Scutellarein, demonstrated binding energies close to or surpassing that of the standard drug PPND (-8.7 kcal/mol), indicating their potential as effective RdRP inhibitors. The interactions primarily involved key residues, including Glu510 and Trp185, emphasizing their significance in ligand stabilization. These findings align with recent research highlighting flavonoids’ antiviral activity against viral RdRPs. The study underscores the promise of natural flavonoids as lead compounds for developing potent Nora Virus inhibitors, warranting further experimental validation and optimization to establish their therapeutic efficacy. Overall, this research exemplifies the utility of in silico methods in accelerating antiviral drug discovery and the potential of phytochemicals in combating emerging viral threats. Keywords: RdRP Nora Virus, PPND, AutoDock, Molecular Docking, In silico, Flavones.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-25
DOI
https://doi.org/10.5281/zenodo.15529855
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Docking Studies of Flavone Derivatives as Inhibitors of RdRP Nora Virus: Computational Insights and Binding Affinity Analysis

Zenodo (CERN European Organization for Nuclear Research)
Genetic Associations and Epidemiology
article

Molecular Docking Studies of Flavone Derivatives as Inhibitors of RdRP Nora Virus: Computational Insights and Binding Affinity Analysis

article en

Abstract

ABSTRACT Human viruses with high mutation rates, such as the Nora Virus, pose significant challenges in biomedical research and antiviral drug development, necessitating the exploration of novel therapeutic strategies. The Nora Virus, classified under the genus Phlebovirus within the family Bunyaviridae, relies on RNA-dependent RNA polymerase (RdRP) for viral RNA replication, making RdRP a crucial target for antiviral intervention. In this study, we employed computational approaches, including molecular docking and molecular dynamics simulations, to investigate the inhibitory potential of selected flavone derivatives retrieved from the PubChem database against Nora Virus RdRP (PDB ID: 4LQ3). Ligands were prepared by optimizing their conformations and converting them into appropriate formats for docking with AutoDock Vina, while the protein structure was processed by removing extraneous molecules and defining the active site around key residues such as Cys196 and Cys305. The docking simulations revealed that Apigenin 7-O-Rutinoside exhibited the highest binding affinity with a binding energy of -9.8 kcal/mol, forming multiple hydrogen bonds and extensive hydrophobic interactions with critical amino acids including Glu510, Gly508, and Tyr341. Several other flavonoids, such as 8-Prenylnaringenin and Scutellarein, demonstrated binding energies close to or surpassing that of the standard drug PPND (-8.7 kcal/mol), indicating their potential as effective RdRP inhibitors. The interactions primarily involved key residues, including Glu510 and Trp185, emphasizing their significance in ligand stabilization. These findings align with recent research highlighting flavonoids’ antiviral activity against viral RdRPs. The study underscores the promise of natural flavonoids as lead compounds for developing potent Nora Virus inhibitors, warranting further experimental validation and optimization to establish their therapeutic efficacy. Overall, this research exemplifies the utility of in silico methods in accelerating antiviral drug discovery and the potential of phytochemicals in combating emerging viral threats. Keywords: RdRP Nora Virus, PPND, AutoDock, Molecular Docking, In silico, Flavones.

Zenodo (CERN European Organization for Nuclear Research)
Kakatiya University (IN)
Good health and well-being
Openalex Percentile: Top 52%
Genetic Associations and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Molecular Docking Studies of Flavone Derivatives as Inhibitors of RdRP Nora Virus: Computational Insights and Binding Affinity Analysis · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS